scholarly article | Q13442814 |
P356 | DOI | 10.1254/FPJ.106.41 |
P953 | full work available at URL | https://www.jstage.jst.go.jp/article/fpj1944/106/1/106_1_41/_pdf |
P698 | PubMed publication ID | 7590522 |
P2093 | author name string | T. Mori | |
H. Kasai | |||
T. Nagayama | |||
K. Saitoh | |||
A. Tsuchiya | |||
S. Ohbayashi | |||
P433 | issue | 1 | |
P407 | language of work or name | Japanese | Q5287 |
P304 | page(s) | 41-50 | |
P577 | publication date | 1995-07-01 | |
P1433 | published in | Folia Pharmacologica Japonica | Q15764489 |
P478 | volume | 106 |
Q44612458 | 2‐Cyclopenten‐1‐one and prostaglandin J2 reduce restenosis after balloon angioplasty in rats: role of NF‐κB |
Q47877643 | Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators |
Q33993678 | Current, new and future treatments in dyslipidaemia and atherosclerosis |
Q30476274 | PPAR alpha inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4a |
Q28289022 | Peroxisome proliferator-activated receptor (PPAR)-alpha: a pharmacological target with a promising future |
Q47726428 | Regulation of apo A-I gene expression by fibrates |
Q35027759 | Regulation of chemokine expression in atherosclerosis |
Q35541858 | Role of Monocytes in Atherogenesis |
Q34047291 | Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis |
Search more.